Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells

The enthusiasm for producing patient-specific human embryonic stem cells using somatic nuclear transfer has somewhat abated in recent years because of ethical, technical, and political concerns. However, the interest in generating induced pluripotent stem cells (iPSCs), in which pluripotency can be obtained by transcription factor transduction of various somatic cells, has rapidly increased. Human iPSCs are anticipated to open enormous opportunities in the biomedical sciences in terms of cell therapies for regenerative medicine and stem cell modeling of human disease. On the other hand, recent reports have emphasized the pitfalls of iPSC technology, including the potential for genetic and epigenetic abnormalities, tumorigenicity, and immunogenicity of transplanted cells. These constitute serious safety-related concerns for iPSC-based cell therapy. However, preclinical data supporting the safety and efficacy of iPSCs are also accumulating. In this Review, recent achievements and future tasks for safe iPSC-based cell therapy are summarized, using regenerative medicine for repair strategies in the damaged central nervous system (CNS) as a model. Insights on safety and preclinical use of iPSCs in cardiovascular repair model are also discussed.

[1]  H. Okano,et al.  Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells , 2012, Cell Research.

[2]  Hideyuki Okano,et al.  Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity , 2012, PloS one.

[3]  H. Okano,et al.  Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.

[4]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[5]  Sheng Ding,et al.  The evolving biology of small molecules: controlling cell fate and identity , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  S. Yamanaka,et al.  Induced pluripotent stem cells: opportunities and challenges , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  Naoki Nishishita,et al.  Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors , 2011, Proceedings of the National Academy of Sciences.

[8]  M. Cleary,et al.  HIF induces human embryonic stem cell markers in cancer cells. , 2011, Cancer research.

[9]  Yoshifumi Kawamura,et al.  Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1 , 2011, Nature.

[10]  Mitsugu Sekimoto,et al.  Reprogramming of mouse and human cells to pluripotency using mature microRNAs. , 2011, Cell stem cell.

[11]  C. Mummery.  Induced pluripotent stem cells--a cautionary note. , 2011, The New England journal of medicine.

[12]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[13]  Mudit Gupta,et al.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.

[14]  C. Svendsen,et al.  Induced pluripotent stem cells: a new revolution for clinical neurology? , 2011, The Lancet Neurology.

[15]  M. Pera,et al.  Stem cells: The dark side of induced pluripotency , 2011, Nature.

[16]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[17]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[18]  Hideki Uosaki,et al.  Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A , 2011, PloS one.

[19]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[20]  H. Okano,et al.  Toward using iPS cells to treat spinal cord injury: Their safety and therapeutic efficacy , 2011 .

[21]  Sheng Ding,et al.  Reprogramming of human primary somatic cells by OCT4 and chemical compounds. , 2010, Cell stem cell.

[22]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[23]  Stephen E. Strauss.  Geron trial resumes, but standards for stem cell trials remain elusive , 2010, Nature Biotechnology.

[24]  Shinya Yamanaka,et al.  Promotion of direct reprogramming by transformation-deficient Myc , 2010, Proceedings of the National Academy of Sciences.

[25]  Hideyuki Okano,et al.  Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury , 2010, Proceedings of the National Academy of Sciences.

[26]  Shinsuke Yuasa,et al.  Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. , 2010, Cell stem cell.

[27]  K. Sakurada.  Environmental epigenetic modifications and reprogramming-recalcitrant genes. , 2010, Stem cell research.

[28]  H. Okano.  Neural stem cells and strategies for the regeneration of the central nervous system , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[29]  S. Yuasa,et al.  G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. , 2010, Cell stem cell.

[30]  Shinya Yamanaka,et al.  Generation of mouse-induced pluripotent stem cells with plasmid vectors , 2010, Nature Protocols.

[31]  Monica Siegenthaler,et al.  Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury , 2009, Stem cells.

[32]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[33]  H. Okano,et al.  Roles of ES Cell-Derived Gliogenic Neural Stem/Progenitor Cells in Functional Recovery after Spinal Cord Injury , 2009, PloS one.

[34]  David R. Liu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[35]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[36]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[37]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[38]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[39]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[40]  A. Hao,et al.  Oct4 is expressed in human gliomas and promotes colony formation in glioma cells , 2009, Glia.

[41]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[42]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[43]  H. Okano,et al.  Cell types to order: temporal specification of CNS stem cells , 2009, Current Opinion in Neurobiology.

[44]  T. Cantz,et al.  Induced pluripotent stem cells generated without viral integration , 2009, Hepatology.

[45]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[46]  A. Koizumi,et al.  Spatiotemporal Recapitulation of Central Nervous System Development by Murine Embryonic Stem Cell‐Derived Neural Stem/Progenitor Cells , 2008, Stem Cells.

[47]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[48]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[49]  Jennifer Nichols,et al.  Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.

[50]  T. Shimazaki,et al.  Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development , 2008, Nature Neuroscience.

[51]  Takashi Aoi,et al.  Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells , 2008, Science.

[52]  M. Araúzo-Bravo,et al.  Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors , 2008, Nature.

[53]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[54]  I. Komuro,et al.  IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis , 2008, Nature.

[55]  H. Okano,et al.  Neural stem cells: involvement in adult neurogenesis and CNS repair , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[56]  C. Lengner,et al.  Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency , 2008, Cell.

[57]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[58]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[59]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[60]  A. Colman,et al.  Highly enriched cardiomyocytes from human embryonic stem cells. , 2008, Cytotherapy.

[61]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[62]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[63]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[64]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[65]  Chris Denning,et al.  Transgenic enrichment of cardiomyocytes from human embryonic stem cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[66]  L. Gepstein,et al.  Identification and selection of cardiomyocytes during human embryonic stem cell differentiation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[68]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[69]  R. Schwartz,et al.  Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development , 2007, Development.

[70]  E. Ballestar,et al.  Notch signaling is essential for ventricular chamber development. , 2007, Developmental cell.

[71]  H. Okano,et al.  A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord , 2006, Nature Medicine.

[72]  Ralf Kettenhofen,et al.  Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium , 2006, The Journal of experimental medicine.

[73]  D. Srivastava.  Making or Breaking the Heart: From Lineage Determination to Morphogenesis , 2006, Cell.

[74]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[75]  M. Nemir,et al.  Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling , 2006, Circulation research.

[76]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[77]  C. Contag,et al.  In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[79]  T. Shimazaki,et al.  Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells , 2005, Nature Biotechnology.

[80]  T. Shimazaki,et al.  Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. , 2004, Developmental biology.

[81]  Rene Spijker,et al.  Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells , 2003, Circulation.

[82]  S. Nishikawa,et al.  Chamber‐specific differentiation of Nkx2.5‐positive cardiac precursor cells from murine embryonic stem cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  Y. Toyama,et al.  Transplantation of neural stem cells into the spinal cord after injury. , 2003, Seminars in cell & developmental biology.

[84]  Y. Yonemitsu,et al.  Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells , 2003, Gene Therapy.

[85]  A. Terzic,et al.  Stem cell differentiation requires a paracrine pathway in the heart , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  H. Okano.  Stem cell biology of the central nervous system , 2002, Journal of neuroscience research.

[87]  M. Mercola,et al.  Wnt antagonism initiates cardiogenesis in Xenopus laevis. , 2001, Genes & development.

[88]  A. Bauer,et al.  Brachyury is a target gene of the Wnt/β-catenin signaling pathway , 2000, Mechanisms of Development.

[89]  A. Bauer,et al.  Brachyury is a target gene of the Wnt/beta-catenin signaling pathway. , 2000, Mechanisms of development.

[90]  G. Koh,et al.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.